Advocacy intelligence hub — real-time data for patient organizations
Sulfamylon solution: FDA approved
For use as an adjunctive topical antimicrobial agent to control bacterial infection when used under moist dressings over meshed autografts on excised burn wounds.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Copay cards
Copay Assistance1
Sulfamylon solution
Mylan Laboratories, Inc.
Browse all Susceptibility to viral and mycobacterial infections due to STAT1 deficiency news →
View all Susceptibility to viral and mycobacterial infections due to STAT1 deficiency specialists →